SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Regeneron Pharmaceuticals
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
3559 104 0 REGN
Emcee:  Patrick Slevin Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2032I really hope REGN isn't pulled off market...Felix B-2/2/2017
2031Repatha score positive, how well ..until 3-17? finance.yahoo.com PS: To considMiljenko Zuanic-2/2/2017
2030Roche is reporting CHF329m ($332m) Lucentis 4Q sale (ver. $376 for 3Q) which is Miljenko Zuanic-2/1/2017
2029Spay is a "spay", nothing more...nothing less.Miljenko Zuanic-1/31/2017
2028Tony Coles joins REGN BOD. investor.regeneron.com "Dr. Coles was nominateBiotech Jim-1/31/2017
2027RTH258 stuff (probably old hat for readers of this board): siliconinvestor.comDewDiligence_on_SI-1/29/2017
2026And they also reported OMER holdings. They (BR) are voting with $$ in this sectBiotech Jim-1/26/2017
2025Sorry for confusion, it is not...they increased holding in BIIB, AMGN, and GILDMiljenko Zuanic-1/25/2017
2024Just to make it clear, their cumulative (based on 6.1 m shares) confidence is hiMiljenko Zuanic-1/25/2017
20236.1 m from 2.3 (3Q-16), that is $~1.4 B confidence! WOWMiljenko Zuanic-1/25/2017
2022Blackrock likes the stock, 5.9% ownership. investor.regeneron.comBiotech Jim-1/25/2017
2021Yes, Roche increase rebate in US, and Novartis in ex-US, in 4Q, to better competMiljenko Zuanic-1/25/2017
2020Ex-US Lucentis had slightly negative QoQ pricing with positive volume growth, acDewDiligence_on_SI-1/25/2017
2019From Novartis, Lucentis ex-US 4Q sale are 452 m (flat, versus 3Q 456 m),,,Bayer Miljenko Zuanic-1/25/2017
2018Asclepius was was a hero and god of medicine in ancient Greek religion and mythoBiotech Jim-1/20/2017
2017That is Sanofi job. Regeneron should go after lawyers if the want to break from Miljenko Zuanic-1/20/2017
2016They should go after some lawyers...Felix B-1/20/2017
2015Should Regeneron go after Asclepix? asclepix.comMiljenko Zuanic-1/19/2017
2014Tyrosine kinase blocking collagen IV–derived peptide suppresses ocular neovasculBiotech Jim-1/19/2017
2013No, 45 days from Jan. 5.Miljenko Zuanic-1/18/2017
2012Nice find. Was it stated somewhere when a final decision/appeal will be decidedFelix B-1/18/2017
2011Very nice (plain language) review of the injunction case, ipwatchdog.comMiljenko Zuanic-1/17/2017
2010They can extend for 3 more years on two specified targets with R&D call for Miljenko Zuanic-1/14/2017
2009Really curious how SNY plays this after 2017 since their Ab collaboration ends. Felix B-1/14/2017
2008They are still far from 30%! It looks as general positive that they are increasiMiljenko Zuanic-1/13/2017
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News